Hongrie And NotEduardo Tolosa
List of bibliographic references
Number of relevant bibliographic references: 12.Ident. | Authors (with country if any) | Title |
---|---|---|
000113 | István Sziklai [Hongrie] ; Judit Szilvássy [Hongrie] ; Zoltán Szilvássy [Hongrie] | Tinnitus control by dopamine agonist pramipexole in presbycusis patients: A randomized, placebo‐controlled, double‐blind study |
000520 | Endre Pal [Hongrie] ; Ferenc Nagy [Hongrie] ; Zsuzsanna Aschermann [Hongrie] ; Eva Balazs [Hongrie] ; Norbert Kovacs [Hongrie] | The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double‐blind, placebo‐controlled study |
000856 | Nikoletta B Di [Hongrie] ; Szabolcs Kéri [Hongrie] ; Helga Nagy [Hongrie] ; Ahmed Moustafa [États-Unis] ; Catherine E. Myers [États-Unis] ; Nathaniel Daw [États-Unis] ; György Dib [Hongrie] ; Annamária Takáts [Hongrie] ; Dániel Bereczki [Hongrie] ; Mark A. Gluck [États-Unis] | Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients |
000B05 | H. F. Harbo [Norvège] ; J. Finsterer [Autriche] ; J. Baets [Belgique] ; C. Van Broeckhoven [Belgique] ; S. Di Donato [Italie] ; B. Fontaine [France] ; P. De Jonghe [Belgique] ; A. Lossos [Israël] ; T. Lynch [Irlande (pays)] ; C. Mariotti [Italie] ; L. Schöls [Allemagne] ; A. Spinazzola [Italie] ; Z. Szolnoki [Hongrie] ; S. J. Tabrizi [Royaume-Uni] ; C. Tallaksen [Norvège] ; M. Zeviani [Italie] ; J. Burgunder [Suisse] ; T. Gasser [Allemagne] | EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias |
000F68 | G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
001766 | Judit Várkonyi [Hongrie] ; Hanna Rosenbaum [Israël] ; Nicole Baumann [France] ; Jennifer J. Mackenzie [Canada] ; Zsuzsa Simon [Hongrie] ; Judith Aharon-Peretz [Israël] ; Jamie M. Walker [États-Unis] ; Nahid Tayebi [États-Unis] ; Ellen Sidransky [États-Unis] | Gaucher disease associated with parkinsonism: Four further case reports |
001976 | Seiichiro Shimazu [Japon] ; Kazue Takahata [Japon] ; Hiroshi Katsuki [Japon] ; Hiroko Tsunekawa [Japon] ; Akie Tanigawa [Japon] ; Fumio Yoneda [Japon] ; Joseph Knoll [Hongrie] ; Akinori Akaike [Japon] | (−)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release |
001D24 | Judit Mally [Hongrie] ; T. W. Stone [Royaume-Uni] | Therapeutic and “dose‐dependent” effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease |
002284 | J. Knoll [Hongrie] | Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes |
002611 | J. Málly [Hongrie] | Some new aspects of the effect of (−)deprenyl in Parkinson's disease—a retrospective study |
002A13 | W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie] | Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study |
002D23 | J. Hullay [Hongrie] | Stereotaxic treatment of patients with Parkinson's disease |
This area was generated with Dilib version V0.6.23. |